Sergio Espinosa Gil
@SergioE32429537
Followers
4
Following
17
Media
0
Statuses
11
Joined July 2019
Happy to share our last work on MAP kinase #ERK5. We describe the #oncogenic MEK5-ERK5 pathway as a critical regulator of #cancer cell #resistance to extrinsic #apoptosis induced by death receptor ligands #TNFa, #FasL, and #TRAIL. https://t.co/tEG7ZBaIHI
7
5
41
Very proud of our *new PhD in the lab* 🙂! Congrats to *Dr. Sergio Espinosa* @SergioE32429537 for an excellent presentation and scientific discussion👌. Big thanks to the PhD Committee Dr Ana Cuenda @CuendaAna, Dr Joan Seoane @seoanelab and Dr Martin Villalba!
4
7
42
En los últimos años, el papel de la proteína #ERK5 en #cáncer está siendo especialmente investigado. #VallHebron ha organizado el primer congreso mundial para establecer las bases de colaboración entre expertos internacionales en este campo. Lee más: https://t.co/VoutWQM39K
0
4
9
Happy to share our latest work on #ERK5 in #endometrial #cancer, where we describe MAP kinase ERK5 and NF-kB pathways as new targets to tackle EC👇 The ERK5/NF-κB signaling pathway targets endometrial cancer proliferation and survival
biorxiv.org
Endometrial cancer (EC) is the most common type of gynaecologic cancer in women of developed countries. Despite surgery combined with chemo-/radiotherapy regimens, overall survival of patients with...
1
3
9
compro 1 entrada de razz dia 13 d'abril #razz #razzmatazz
1
0
0
Un equip de #recercaUAB de l’@INC_UAB identifica una nova via per atacar les cèl·lules tumorals ➡ https://t.co/5GxdBPP3mY
#UAB @IQAC_CSIC @JoseLizk @AbilityPharma @PRUAB @ICOnoticies @unicomplutense @VHIR_ @VHIO @idibell_cat
3
22
84
"AbilityPharma publishes full characterization of mechanism of action of ABTL0812, a Phase II clinical autophagy inducer in cancer cells, in Autophagy" https://t.co/TzIScQp54Z by @CDomenech_APh on @LinkedIn
linkedin.com
BARCELONA – June 9, 2020 - The biopharmaceutical company Ability Pharmaceuticals SL announced today that the full description of the mechanism of action of ABTL0812 has been published in the presti...
0
6
15
Check our last work on dihydroceramides causing ER stress-mediated cytotoxic autophagy in cancer cells, published in Autophagy. Mechanism revealed using the new antitumor drug ABTL0812, currently in phase II clinical trial lead by @AbilityPharma 👇 https://t.co/V9c0IwaogE
4
17
39
🟢SORTEO 72.000 FIFA POINTS para los TOTS🟢 -Participas si me sigues y das RT a este tuit, fácil y rápido. 6 ganadores, mucha suerte papus ♥️
2K
55K
33K
Sergio, PhD student in our lab (@JoseLizk) won the prize to best SEBBM poster: ERK5 mediates EGF-induced cancer cell proliferation @42congresoSEBBM.
3
8
37